Total planned funding: $348,353,861
Allocations
Countries/Regions
| Eswatini | $348,353,861 |
Organizational Types
| Private Contractor | $90,694,472 |
| University | $62,476,350 |
| Unknown | $62,029,685 |
| NGO | $61,321,481 |
| Own Agency | $41,048,630 |
| Host Country Government Agency | $10,931,898 |
| FBO | $10,806,488 |
| Multi-lateral Agency | $4,335,650 |
| Other USG Agency | $4,092,376 |
| Implementing Agency | $616,831 |
Program Areas
| Treatment | $99,374,056 |
| Care | $91,116,140 |
| Prevention | $67,840,647 |
| Governance and Systems | $38,125,467 |
| Management and Operations | $26,713,630 |
| Testing | $25,183,921 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $79,862,516 |
| HBHC: Care: Adult Care and Support | $36,599,909 |
| HKID: Care: Orphans and Vulnerable Children | $33,127,401 |
| HVMS: Management and Operations | $26,713,630 |
| HVCT: Testing: HIV Testing and Counseling | $25,183,921 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,353,166 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $22,057,172 |
| OHSS: Health Systems Strengthening | $16,153,400 |
| HVSI: Strategic Information | $15,416,012 |
| HVTB: Care: TB/HIV | $15,083,984 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,917,841 |
| HTXD: Treatment: ARV Drugs | $12,348,524 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,005,468 |
| PDTX: Treatment: Pediatric Treatment | $7,163,016 |
| HLAB: Laboratory Infrastructure | $6,556,055 |
| PDCS: Care: Pediatric Care and Support | $6,304,846 |
| HMBL: Biomedical Prevention: Blood Safety | $507,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$52,252,667
Countries/Regions
Not Available:
$43,066,832
Countries/Regions
Pact, Inc.:
$39,077,378
Countries/Regions
USG Aggregated Agencies:
$18,862,608
Countries/Regions